Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

April 26 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO
    * Q1 NET SALES SEK 42.5 MILLION VERSUS SEK 37.5 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr7GxKF4 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news